000 01157 a2200337 4500
005 20250513071932.0
264 0 _c19940304
008 199403s 0 0 eng d
022 _a0004-5632
024 7 _a10.1177/000456329303000605
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aColbert, D L
245 0 0 _aReducing the cost of phenytoin assays with in-house TDx reagents.
_h[electronic resource]
260 _bAnnals of clinical biochemistry
_cNov 1993
300 _a555-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCalibration
650 0 4 _aChromatography, Thin Layer
650 0 4 _aCost-Benefit Analysis
650 0 4 _aDrug Monitoring
_xeconomics
650 0 4 _aFluorescein-5-isothiocyanate
650 0 4 _aFluorescence Polarization Immunoassay
_xeconomics
650 0 4 _aHumans
650 0 4 _aImmune Sera
650 0 4 _aIndicators and Reagents
650 0 4 _aPhenytoin
_xblood
700 1 _aTurner, G J
700 1 _aGooch, J C
773 0 _tAnnals of clinical biochemistry
_gvol. 30 ( Pt 6)
_gp. 555-8
856 4 0 _uhttps://doi.org/10.1177/000456329303000605
_zAvailable from publisher's website
999 _c8304003
_d8304003